• Vertex Pharmaceuticals' (VRTX) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

    来源: Buzz FX / 11 2月 2025 10:56:10   America/New_York


    Vertex Pharmaceuticals' (VRTX) "Overweight" Rating Reaffirmed at Cantor Fitzgerald Written by MarketBeat February 11, 2025 Share Link copied to clipboard. Vertex Pharmaceuticals ( NASDAQ:VRTX - Get Free Report ) 's stock had its "overweight
    Read more...
分享